• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Pharmaceuticals

    Recent news which mentions Pharmaceuticals

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    32 33 Next >
    FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
    Tags Bristol/Myers Squibb Co Biotech and Pharmaceuticals Health care industry
    From CNBC.com News
    Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study
    Tickers ENTA NEWS
    Tags Biotech Health Care pharmaceuticals
    From Benzinga
    Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
    Tags Health care industry Eli Lilly and Co Novo Nordisk A/S
    From CNBC.com News
    Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
    Tickers LLY MRK NEWS
    Tags Briefs Stories That Matter Benzinga
    From Benzinga
    Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
    Tags Social issues Biotechnology Companies
    From CNBC.com News
    Commentary: Congress has just weeks to help children with rare diseases
    Tags Government & Regulations Pharmaceuticals Politics
    From Business Journals
    FTC sues drug middlemen for allegedly inflating insulin prices
    Tags UnitedHealth Group Inc Health care industry Eli Lilly and Co
    From CNBC.com News
    Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
    Tickers ABT NEWS RBGLY
    Tags Analyst Color Market News Piper Sandler
    From Benzinga
    Novartis not joining the 'frenzy' of weight loss drugs, CEO says
    Tags Health care industry Eli Lilly and Co Novartis AG
    From CNBC.com News
    Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
    Tags Health care industry Cancer Biotech and Pharmaceuticals
    From CNBC.com News
    Biotech raises $315 million in IPO, surpassing $250M target
    Tags Pharmaceuticals Bizwomen Biotech
    From Business Journals
    Why Analyst Says Rare Disease-Focused Inozyme Pharma Stock 'Could Be Worth A Look'
    Tickers INZY NEWS
    Tags Expert Ideas Briefs Biotech
    From Benzinga
    Biotech upsizes target for pending IPO to $250M
    Tags Biotech Insurance Health Care
    From Business Journals
    Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
    Tags Technology Enterprise Hospitals
    From CNBC.com News
    Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
    Tags Science Pharmaceuticals Business
    From CNBC.com News
    Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
    Tags US: News Companies Biotechnology
    From CNBC.com News
    AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
    Tags Companies AstraZeneca PLC Europe News
    From CNBC.com News
    EYEN Shares Are Trading Higher Today: What You Need To Know
    Tickers EYEN NEWS
    Tags Movers Biotech pharmaceuticals
    From Benzinga
    Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
    Tags Biotech and Pharmaceuticals Health care industry Eisai Co Ltd
    From CNBC.com News
    AstraZeneca says staff detained in China amid reports of a drug-import investigation
    Tags AstraZeneca PLC Biotechnology Business News
    From CNBC.com News
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    32 33 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.